news
Marc Dunoyer appointed Chief Financial Officer of AstraZeneca
"Following a thorough and extensive search it became clear that Marc possessed the rare blend of financial, business and science experience..."
List view / Grid view
Appointments
news
Roger M. Perlmutter appointed as President of Merck Research Laboratories
7 March 2013 | By Merck
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Roger M. Perlmutter, M.D., Ph.D., as executive vice president and president of Merck Research Laboratories (MRL), effective April 15. Dr. Perlmutter will succeed Peter S. Kim, Ph.D., who has served in the role…
news
Jean-Marc Pardonge appointed as new President of Aptar Pharma Prescription Division
Jean-Marc Pardonge, 52 years old, has been appointed as the new President of Aptar Pharma’s Prescription Division, world leader in the development and manufacturing of nasal and pulmonary drug delivery devices.
news
Pascal Soriot appointed Chief Executive Officer of AstraZeneca
AstraZeneca today announced that Pascal Soriot has been appointed as the company’s Chief Executive Officer. Pascal Soriot will take on his new responsibilities and join the AstraZeneca PLC Board as an Executive Director on 1 October 2012.
news
Biomarker specialist Activiomics appoints Dr Trevor Nicholls as Non-Executive Chairman
27 March 2012 | By College Hill
Activiomics Limited., the developer of innovative biomarker technologies has announced the appointment of industry leader Dr Trevor Nicholls to its Board as Non-Executive Chairman.
news
Stuart Grant appointed Patheon’s Executive Vice President, Chief Financial Officer
Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that Stuart Grant has been appointed Patheon's Executive Vice President, Chief Financial Officer. Mr. Grant comes to Patheon following an accomplished career with increasing levels of responsibility in finance for several…
news
Antonella Mancuso appointed Patheon’s President, Global Commercial Operations and Chief Manufacturing Officer
Patheon (TSX: PTI) a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that Antonella Mancuso has been promoted to President, Global Commercial Operations and Chief Manufacturing Officer, responsible for Patheon's global commercial manufacturing operations . Ms. Mancuso will assume responsibility for all of…
news
Richard Daniell appointed as Managing Director of Teva UK Limited
Teva UK Limited has announced that Richard Daniell has been appointed as Managing Director, responsible for all Teva’s commercial activities in the UK.
news
Anirvan Ghosh named Head of Discovery for Roche’s CNS
21 February 2011 | By Roche
Role will focus on disorders such as schizophrenia, neurodegeneration, treatment-resistant depression & neurodevelopment...
news
Clondalkin Group appoints Peach to support pharma growth
14 February 2011 | By Adessi
Clondalkin Group has appointed Paul Peach to support its growth strategy within pharmaceuticals and healthcare...
news
NextPharma Technologies appoint new Quality Director at its Braine-l’Alleud site in Belgium
3 February 2011 | By NextPharma Technologies
NextPharma the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical and biotech industry, is pleased to announce the appointment of Brigitte Genard as Quality Director at its sterile contract development and manufacturing site in Braine-l’Alleud, Belgium.
news
Michael Cann picks up the reins at the BGMA
26 May 2010 | By College Hill
Michael Cann, Director Generics at Actavis, took over as Chairman of the BGMA at the Association’s AGM in London on 26 May. He replaces Kim Innes of Teva, who will serve as Vice Chair for a year.
